| 英文别名 |
N-[1-(3-Fluoropropyl)azetidin-3-yl]-6-[(6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-3,6,8,9-tetrahydrop;AZD9833;JUP57A8EPZ;Camizestrant;Camizestrant [USAN];NSC828717;WHO 11592;AZ14066724;3-Pyridinamine, N-(1-(3-fluoropropyl)-3-azetidinyl)-6-((6S,8R)-6,7,8,9-tetrahydro-8-methyl-7-(2,2,2-trifluoroethyl)-3H-pyrazolo(4,3-F)isoquinolin-6-yl)-;Unii-jup57A8epz;AZD-9833;CHEMBL4650365;NSC-828717;SCHEMBL20089710;GTPL12716;CS-0121043;WDHOIABIERMLGY-CMJOXMDJSA-N;2222844-89-3;N-(1-(3-FLUOROPROPYL)-3-AZETIDINYL)-6-((6S,8R)-8-METHYL-7-(2,2,2-TRIFLUOROETHYL)-6,7,8,9-TETRAHYDRO-3H-PYRAZOLO(4,3-F)ISOQUINOLIN-6-YL)-3-PYRIDINAMINE;AZD 9833;DA-61390;AT22885;N-[1-(3-fluoropropyl)azetidin-3-yl]-6-[(6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-3,6,8,9-tetrahydropyrazolo[4,3-f]isoquinolin-6-yl]pyridin-3-amine;AZ-14066724;AZD9833?;CAMIZESTRANT [INN];compound 28 PMID: 32910656];AKOS040733130;N-(1-(3-fluoropropyl)azetidin-3-yl)-6-((6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)pyridin-3-amine;CAMIZESTRANT [WHO-DD];SERD AZD9833;MS-28839;Selective Estrogen Receptor Degrader AZD9833;EX-A5025;HY-136255 |